SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-083761
Filing Date
2024-07-16
Accepted
2024-07-16 06:30:13
Documents
13
Period of Report
2024-07-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nktx-20240710.htm   iXBRL 8-K 55094
2 EX-99.1 nktx-ex99_1.htm EX-99.1 24177
3 GRAPHIC img220989892_0.jpg GRAPHIC 17658
  Complete submission text file 0000950170-24-083761.txt   231652

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT nktx-20240710.xsd EX-101.SCH 28004
15 EXTRACTED XBRL INSTANCE DOCUMENT nktx-20240710_htm.xml XML 4705
Mailing Address 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080 (925) 407-1049
Nkarta, Inc. (Filer) CIK: 0001787400 (see all company filings)

IRS No.: 474515206 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39370 | Film No.: 241118561
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)